| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |